Cloning and functional characterization of the human fractalkine receptor promoter regions

Alexandre Garin1, Philippe Pellet, Philippe Deterre

  • 1Laboratoire d'Immunologie Cellulaire et Tissulaire, INSERM U543, Hôpital Pitié-Salpêtrière, 91 Boulevard de l'Hôpital, AP-HP, 75634 Paris cedex 13, France.

The Biochemical Journal
|September 18, 2002
PubMed

Insights

Reduced expression of the fractalkine receptor, CX3CR1, impacts HIV and heart disease. This study reveals CX3CR1 gene regulation involves three promoters and alternative splicing, allowing precise cell-specific expression.

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • Reduced fractalkine receptor (CX3CR1) expression correlates with faster HIV progression and lower acute coronary event risk.
  • Understanding CX3CR1 transcriptional regulation is crucial for elucidating its role in disease.

Purpose of the Study:

  • To structurally and functionally characterize the CX3CR1 gene.
  • To elucidate the mechanisms of CX3CR1 transcriptional regulation.

Main Methods:

  • Gene structure and functional analysis of the CX3CR1 gene.
  • Identification and characterization of promoter activities and transcript variants.
  • Analysis of alternative splicing in different cell types.

Main Results:

  • The CX3CR1 gene comprises four exons and three introns, spanning over 18 kb.
  • Three distinct mature messenger transcripts are generated through alternative splicing of untranslated exons with exon 4.
  • Constitutive promoter activity upstream of exons 1 and 2 was identified, with cell-specific enhancement by these exons.

Conclusions:

  • The CX3CR1 gene exhibits complex transcriptional regulation involving three distinct promoter regions.
  • Alternative splicing and promoter usage allow for versatile and precise CX3CR1 expression in various cell types.
  • This intricate regulation likely contributes to CX3CR1's diverse roles in health and disease.